Heilongjiang Zuokang Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Heilongjiang Zuokang Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KOKOCL. The owner is based in Linkou County.

Room 012, Building 7, Yong'anhuayuan

Community, Diaoling Town,

Linkou County 157606 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOKOCL
KOKOCL
Registered 2024

Trademark Classifications

Heilongjiang Zuokang Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Heilongjiang Zuokang Biotechnology Co., Ltd. have?

Heilongjiang Zuokang Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Heilongjiang Zuokang Biotechnology Co., Ltd. file in?

Heilongjiang Zuokang Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Heilongjiang Zuokang Biotechnology Co., Ltd.'s most well-known trademarks?

Heilongjiang Zuokang Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as KOKOCL. These are among 1 currently registered trademark in the portfolio.

What is Heilongjiang Zuokang Biotechnology Co., Ltd.'s trademark registration success rate?

Heilongjiang Zuokang Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.